Acquisition of thyrotropin alfa 0.9 mg inj. for the pharmacy department

Auto-translated from Spanish

Original title: Adquisicion de tirotropina alfa 0.9 mg iny, para departamento de farmacia

INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS

Published: Nov 17, 2014

Updated: Jun 14, 2026

Source: peru_seace

This tender has been awarded

Awarded to GENZYME DEL PERU S.A.C. — PEN 39,664

Browse open Governance & Public Administration tenders in Peru

About This Opportunity

Translated

Acquisition of thyrotropin alfa 0.9 mg injections for the pharmacy department of the National Institute of Neoplastic Diseases.

This is a supplies contract in the governance and public administration sector. Located in Peru, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of PEN 39,664.

Published through Peru SEACE, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Original language: Spanish

ADQUISICION DE TIROTROPINA ALFA 0.9 mg INY, PARA DEPARTAMENTO DE FARMACIA

Entidad contratante: INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS

Departamento: LIMA

Proceso: AMC-CLASICO-166-2014-INEN-1

Metodo de contratacion: Adjudicación de Menor Cuantía

Data provenance

This notice is sourced from Peru SEACE and was originally published on November 17, 2014. Last refreshed 12 days ago. Reference: 55397. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS

INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS has issued 125 procurement notices on BidsFactory, including 2 currently open and 105 awarded contracts. Activity concentrates in Governance & Public Administration, General Supplies & Services, and Health & Medical. All notices are published for Peru. Notices are distributed via Peru SEACE. Most recent publication: May 29, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Peru. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Peru SEACE to access the full notice, required documents, and submission instructions. Quote reference 55397 when communicating with the contracting authority.

Is this tender still open?

No — the contract has already been awarded to GENZYME DEL PERU S.A.C.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS in Peru. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Governance & Public Administration sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

GENZYME DEL PERU S.A.C. was awarded the contract for PEN 39,664. The figure reflects the value disclosed by the contracting authority in the award notice.